ICAM1 and COVID-19: Our group previously described the presence of activated endothelial cells and elevated levels of biomarkers associated with vascular injury, including ICAM-1, ANGPT-2, and IL-1β, as well as increased expression of angiogenesis markers such as VEGF in fatal COVID-19 cases, compared to both H1N1 and control groups [29].